First Hospital of Shijiazhuang City
4 clinical trials · Sponsor
◉ Watch First Hospital of Shijiazhuang City
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer (NCT04487093) | First Hospital of Shijiazhuang City | 2020-05-17 |
| Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC (NCT03780283) | First Hospital of Shijiazhuang City | 2019-01-01 |
| Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative (NCT03765775) | First Hospital of Shijiazhuang City | 2018-11-20 |
| Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients (NCT03664843) | First Hospital of Shijiazhuang City | 2018-11-09 |
Track First Hospital of Shijiazhuang City automatically
Every clearance here is in the API, with alerts when new ones post.